2012年7月4日
As a leading global communications company that provides globalization and language solutions for businesses around the world, CSOFT has high expectations for Chinese firms looking to go global.
Such business is expected to generate a quarter of the company’s revenue next year, whereas in the past, revenue was dominated by Fortune 500 clients requiring localization support in China.
Shunee Yee, president and CEO of CSOFT, said Chinese firms are transforming themselves from OEM manufacturers for other brands into “world-class partners”, which has added value to the global supply chain. Yee said this is comparable to China opening a new Silk Road to the West.
Click here to read the full article in China Daily
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com
